ZA907111B - Substituted urea compounds and their preparation and use - Google Patents
Substituted urea compounds and their preparation and useInfo
- Publication number
- ZA907111B ZA907111B ZA907111A ZA907111A ZA907111B ZA 907111 B ZA907111 B ZA 907111B ZA 907111 A ZA907111 A ZA 907111A ZA 907111 A ZA907111 A ZA 907111A ZA 907111 B ZA907111 B ZA 907111B
- Authority
- ZA
- South Africa
- Prior art keywords
- alkyl
- substituted
- cycloalkyl
- urea compounds
- preparation
- Prior art date
Links
- 150000003672 ureas Chemical class 0.000 title abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 abstract 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 abstract 1
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical class FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Treating Waste Gases (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Lubricants (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK443489A DK443489D0 (da) | 1989-09-08 | 1989-09-08 | Substituerede urinstofforbindelser, deres fremstilling og anvendelse |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA907111B true ZA907111B (en) | 1991-07-31 |
Family
ID=8133482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA907111A ZA907111B (en) | 1989-09-08 | 1990-09-06 | Substituted urea compounds and their preparation and use |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5330990A (xx) |
| EP (2) | EP0491770A1 (xx) |
| JP (1) | JPH05505171A (xx) |
| AT (1) | ATE106885T1 (xx) |
| AU (1) | AU639487B2 (xx) |
| CA (1) | CA2066696A1 (xx) |
| DE (1) | DE69009646T2 (xx) |
| DK (2) | DK443489D0 (xx) |
| ES (1) | ES2054309T3 (xx) |
| FI (1) | FI921005A0 (xx) |
| HU (1) | HU208433B (xx) |
| IE (1) | IE69266B1 (xx) |
| IL (1) | IL95440A (xx) |
| NO (1) | NO300460B1 (xx) |
| NZ (1) | NZ235117A (xx) |
| PT (1) | PT95248B (xx) |
| WO (1) | WO1991003475A1 (xx) |
| ZA (1) | ZA907111B (xx) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8922622D0 (en) * | 1989-10-07 | 1989-11-22 | Wyeth John & Brother Ltd | Aroylureas |
| DK40890D0 (da) * | 1990-02-16 | 1990-02-16 | Ferrosan As | Substituerede urinstofforbindelser, deres fremstilling og anvendelse |
| GB9106571D0 (en) * | 1991-03-27 | 1991-05-15 | Erba Carlo Spa | Derivatives of substituted imidazol-2-one and process for their preparation |
| FR2677019B1 (fr) * | 1991-05-27 | 1994-11-25 | Pf Medicament | Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique. |
| GB9120628D0 (en) * | 1991-09-27 | 1991-11-06 | Fujisawa Pharmaceutical Co | Pyrrolobenzoxazine derivatives and process for preparation thereof |
| GB9121835D0 (en) * | 1991-10-15 | 1991-11-27 | Smithkline Beecham Plc | Pharmaceuticals |
| GB9206989D0 (en) * | 1992-03-31 | 1992-05-13 | Glaxo Group Ltd | Chemical compounds |
| EP0640081B1 (en) * | 1992-03-31 | 2000-01-12 | Glaxo Group Limited | Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht4 antagonists |
| GB9214184D0 (en) * | 1992-07-03 | 1992-08-12 | Smithkline Beecham Plc | Pharmaceuticals |
| GB9307400D0 (en) * | 1993-04-08 | 1993-06-02 | Smithkline Beecham Plc | Compounds |
| US5773459A (en) * | 1995-06-07 | 1998-06-30 | Sugen, Inc. | Urea- and thiourea-type compounds |
| CA2249410C (en) * | 1996-03-20 | 2007-06-12 | Wake Forest University | Sigma-2 receptors as biomarkers of tumor cell proliferation |
| US6676925B1 (en) | 1996-03-20 | 2004-01-13 | Wake Forest University | Sigma-2 receptors as biomarkers of tumor cell proliferation |
| DE19643037A1 (de) * | 1996-10-18 | 1998-04-23 | Boehringer Ingelheim Kg | Neue Oxadiazole, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
| US6660529B2 (en) * | 1998-07-28 | 2003-12-09 | Pe Corporation | Heteroaryl substituted benzothiazole dioxetanes |
| US6693202B1 (en) | 1999-02-16 | 2004-02-17 | Theravance, Inc. | Muscarinic receptor antagonists |
| UA73543C2 (uk) | 1999-12-07 | 2005-08-15 | Тераванс, Інк. | Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором |
| CA2392028C (en) | 1999-12-07 | 2009-08-18 | Theravance, Inc. | Carbamate derivatives having muscarinic receptor antagonist activity |
| WO2001080905A2 (en) | 2000-04-27 | 2001-11-01 | Wake Forest University Health Sciences | Sigma-2 receptors as biomarkers of tumor cell proliferation |
| US20050069976A1 (en) * | 2001-02-14 | 2005-03-31 | Peter Lind | Protein-coupled receptor |
| PE20040950A1 (es) | 2003-02-14 | 2005-01-01 | Theravance Inc | DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS |
| US7345060B2 (en) | 2003-11-21 | 2008-03-18 | Theravance, Inc. | Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| GB0602778D0 (en) | 2006-02-10 | 2006-03-22 | Glaxo Group Ltd | Novel compound |
| KR20230043024A (ko) | 2020-07-24 | 2023-03-30 | 젠자임 코포레이션 | 벤글루스타트를 포함하는 제약 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0158265A2 (en) | 1984-04-13 | 1985-10-16 | Beecham Group Plc | Benzamide and anilide derivatives |
| EP0235878A3 (en) * | 1986-01-16 | 1989-06-14 | Beecham Group Plc | Novel compounds |
| AU611976B2 (en) * | 1987-12-24 | 1991-06-27 | John Wyeth & Brother Limited | Aroyl urea and carbamic acid derivatives of azabicyclo compounds |
| DK40890D0 (da) * | 1990-02-16 | 1990-02-16 | Ferrosan As | Substituerede urinstofforbindelser, deres fremstilling og anvendelse |
-
1989
- 1989-09-08 DK DK443489A patent/DK443489D0/da not_active Application Discontinuation
-
1990
- 1990-08-21 IL IL9544090A patent/IL95440A/en not_active IP Right Cessation
- 1990-08-24 IE IE308290A patent/IE69266B1/en not_active IP Right Cessation
- 1990-08-31 NZ NZ235117A patent/NZ235117A/en unknown
- 1990-09-06 JP JP2512602A patent/JPH05505171A/ja active Pending
- 1990-09-06 WO PCT/DK1990/000232 patent/WO1991003475A1/en not_active Application Discontinuation
- 1990-09-06 CA CA002066696A patent/CA2066696A1/en not_active Abandoned
- 1990-09-06 DE DE69009646T patent/DE69009646T2/de not_active Expired - Fee Related
- 1990-09-06 ZA ZA907111A patent/ZA907111B/xx unknown
- 1990-09-06 EP EP90913477A patent/EP0491770A1/en active Pending
- 1990-09-06 HU HU92776A patent/HU208433B/hu not_active IP Right Cessation
- 1990-09-06 EP EP90610056A patent/EP0419397B1/en not_active Expired - Lifetime
- 1990-09-06 AT AT90610056T patent/ATE106885T1/de not_active IP Right Cessation
- 1990-09-06 ES ES90610056T patent/ES2054309T3/es not_active Expired - Lifetime
- 1990-09-06 DK DK90610056.5T patent/DK0419397T3/da active
- 1990-09-06 AU AU63414/90A patent/AU639487B2/en not_active Ceased
- 1990-09-07 PT PT95248A patent/PT95248B/pt not_active IP Right Cessation
-
1992
- 1992-03-03 NO NO920833A patent/NO300460B1/no unknown
- 1992-03-06 FI FI921005A patent/FI921005A0/fi not_active Application Discontinuation
- 1992-09-17 US US07/947,073 patent/US5330990A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0491770A1 (en) | 1992-07-01 |
| IE903082A1 (en) | 1991-03-13 |
| CA2066696A1 (en) | 1991-03-09 |
| IL95440A (en) | 1994-07-31 |
| NO920833L (no) | 1992-03-03 |
| HUT61019A (en) | 1992-11-30 |
| PT95248B (pt) | 1997-06-30 |
| AU6341490A (en) | 1991-04-08 |
| ATE106885T1 (de) | 1994-06-15 |
| EP0419397B1 (en) | 1994-06-08 |
| JPH05505171A (ja) | 1993-08-05 |
| IE69266B1 (en) | 1996-08-21 |
| DE69009646D1 (de) | 1994-07-14 |
| AU639487B2 (en) | 1993-07-29 |
| PT95248A (pt) | 1991-05-22 |
| DE69009646T2 (de) | 1995-01-12 |
| NO920833D0 (no) | 1992-03-03 |
| ES2054309T3 (es) | 1994-08-01 |
| DK0419397T3 (da) | 1994-10-10 |
| US5330990A (en) | 1994-07-19 |
| IL95440A0 (en) | 1991-06-30 |
| FI921005A0 (fi) | 1992-03-06 |
| NZ235117A (en) | 1993-02-25 |
| HU9200776D0 (en) | 1992-08-28 |
| DK443489D0 (da) | 1989-09-08 |
| WO1991003475A1 (en) | 1991-03-21 |
| EP0419397A1 (en) | 1991-03-27 |
| NO300460B1 (no) | 1997-06-02 |
| HU208433B (en) | 1993-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA907111B (en) | Substituted urea compounds and their preparation and use | |
| EP0279512A3 (en) | Use of certain 5-ht3 receptor antagonists in the treatment of visceral pain | |
| CS133491A3 (en) | Therapeutically active compounds | |
| ZA89389B (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
| ZA911103B (en) | Substituted urea compounds and their preparation and use | |
| PT92524A (pt) | Processo para a preparacao de derivados de indole | |
| NO895023D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive aminderivater. | |
| IE812890L (en) | Benzodiazepine compounds | |
| DK544689D0 (da) | Terapeutisk aktive forbindelser | |
| PH24046A (en) | Derivatives of n-(2-pyrrolidinylmethyl)-benzamide and pharmaceutical preparation containing them | |
| HUT65376A (en) | Process for preparing n,n',n-trisubstituted 5-(diamino-methylene)-1,3-dioxane-4,6-diones and pharmaceutical compositions containing them as active ingredient | |
| EP0420464A3 (en) | 3-isoxazolone derivatives, their preparation and their therapeutic uses |